The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Effects of Six Months of Clozapine Treatment on the Quality of Life of Chronic Schizophrenic Patients
Abstract
The effect of approximately six months of treatment with clozapine on the quality of life of 38 treatment-resistant schizophrenic patients was prospectively studied in an open trial. The Quality of Life Scale was used to provide an objective measure of changes in patients' psychosocial functioning. Significant improvement was noted on all four factors of the scale. The ratings tended to be negatively correlated with ratings on the Brief Psychiatric Rating Scale at baseline and at six months. At 12 months, patients' rehospitalization rate was reduced by 83 percent and was independent of the six-month quality-of-life ratings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. (1984) · Schizophrenia Bulletin · doi:10.1093/schbul/10.3.388 · Cited by 1,688
The Prediction of Outcome in Schizophrenia: I. Characteristics of Outcome
Strauss, J. S. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750300011002 · Cited by 791
The Well-being of Chronic Mental Patients: Assessing Their Quality of Life
Lehman, A. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790040023003 · Cited by 603
Lindström, L. H. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb05164.x · Cited by 246
The Prognosis of Schizophrenia: Rationale for a Multidimensional Concept*
Strauss, J. S., & Carpenter, W. T. (1978) · Schizophrenia Bulletin · doi:10.1093/schbul/4.1.56 · Cited by 99
Prädiktoren des Verlaufs schizophrener Erkrankungen unter neuroleptischer Langzeitmedikation
Gäebel, W., Pietzcker, A., & Poppenberg, A. (1981) · Pharmacopsychiatry · doi:10.1055/s-2007-1019594 · Cited by 22
Cited by
A Critical Appraisal of the Quality of Quality-of-Life Measurements
Gill, T. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520080061045 · Cited by 2,208
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.975 · Cited by 701
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 620
A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory Schizophrenia
Rosenheck, R., Cramer, J., Xu, W., Thomas, J., Henderson, W., Frisman, L., Fye, C., & Charney, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371202 · Cited by 516
Treatment-Resistant Schizophrenia - The Role of Clozapine
Meltzer, H. Y. (1997) · Current Medical Research and Opinion · doi:10.1185/03007999709113338 · Cited by 491
Self-citationPsychiatric Symptoms and Quality of Life in Schizophrenia: A Meta-Analysis
Eack, S. M., & Newhill, C. E. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl071 · Cited by 437
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.2.183 · Cited by 436
Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.1.20 · Cited by 388
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1744 · Cited by 382
Management of treatment resistance in schizophrenia
Conley, R. R., & Kelly, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01271-9 · Cited by 352
Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs
Naber, D., Moritz, S., Lambert, M., Rajonk, F., Holzbach, R., Mass, R., Andresen, B., Frank, P., Rüdiger, H., Reinhard, M., et al. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00166-3 · Cited by 348
Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., Larkin, C., & O'Callaghan, E. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09835.x · Cited by 332
Measures of quality of life among persons with severe and persistent mental disorders
Lehman, A. F. (1996) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00801903 · Cited by 320
Mechanisms of action of atypical antipsychotic drugs: a critical analysis
Kinon, B. J., & Lieberman, J. A. (1996) · Psychopharmacology · doi:10.1007/bf02245602 · Cited by 317
Swartz, M. S., Perkins, D. O., Stroup, T. S., Davis, S. M., Capuano, G., Rosenheck, R. A., Reimherr, F., McGee, M. F., Keefe, R. S. E., McEvoy, J. P., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.428 · Cited by 291
First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome
Malla, A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi031 · Cited by 288
Buchanan, R. W., Holstein, C., & Breier, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90082-5 · Cited by 281
Borison, R. L., Arvanitis, L. A., & Milier, B. G. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604000-00008 · Cited by 268
Clozapine for treatment-refractory mania
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.759 · Cited by 265
Schulte, P. F. J. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342070-00001 · Cited by 264
VORUGANTI, L., HESLEGRAVE, R., AWAD, A. G., & SEEMAN, M. V. (1998) · Psychological Medicine · doi:10.1017/s0033291797005874 · Cited by 260
Dimensions of Outcome with Clozapine
Meltzer, H. Y. (1992) · British Journal of Psychiatry · doi:10.1192/s000712500029692x · Cited by 252
Self-citationA systematic review of the evidence of clozapine's anti-aggressive effects
Frogley, C., Taylor, D., Dickens, G., & Picchioni, M. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571100201x · Cited by 252
Quality of life as patient-reported outcomes: principles of assessment
Bullinger, M., & Quitmann, J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.2/mbullinger · Cited by 158
Clozapine Eligibility Among State Hospital Patients
Essock, S. M., Hargreaves, W. A., Dohm, F.-A., Goethe, J., Carver, L., & Hipshman, L. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.1.15 · Cited by 107
Slow-wave sleep and symptomatology in schizophrenia and related psychotic disorders
Keshavan, M. S., Miewald, J., Haas, G., Sweeney, J., Ganguli, R., & Reynolds, C. F. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(95)00023-x · Cited by 63
Holcomb, W. R., Morgan, P., Adams, N. A., Farrel, M., & Ponder, H. M. (1993) · Journal of Clinical Psychology · doi:10.1002/1097-4679(199311)49:6<830::aid-jclp2270490610>3.0.co;2-1 · Cited by 27
Metadata
- Authors
- Meltzer, H. Y., Burnett, S., Bastani, B., & Ramirez, L. F.
- Venue
- Psychiatric Services
- Published
- 1990-08
- Volume
- 41
- Issue
- 8
- Pages
- 892-897
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2038449754
- Cited by
- 338
- References
- 9
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.